John Oyler, Chief Executive Officer at BeOne Medicines Ltd. (ONC), sold 6,600 shares at $256.49 ($1.7M) on 2025-06-17, disclosed to the SEC on 2025-06-18.
Open-market sale of $1.7M ONC by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $266.05 | 3,680 | $979K | 56.7% |
| 2 | $256.49 | 1,460 | $374K | 21.7% |
| 3 | $256.49 | 1,460 | $374K | 21.7% |
| Total | $261.82 avg | 6,600 | $1.7M | 100% |
| Filing → |
| ONC | SELL | 2026-07-17 | $20.2M | — | Filing → |
| ONC | SELL | 2026-07-17 | $89.4M | — | Filing → |
| ONC | SELL | 2026-07-14 | $18.3M | — | Filing → |